Deal Of The Week: Will Heated Competition To Buy Out Ache Laboratorios Muddy The Brazilian Waters?

Pfizer, Novartis and Abbott reportedly are battling to buy out family-owned Ache, Brazil’s leader in prescription drug sales.

Could a bidding war for Brazil’s privately held Ache Laboratorios do for Latin America what Abbott Laboratories Inc.’s gargantuan purchase of part of India’s Piramal Enterprises Ltd. did for biopharma M&A in India?

Call it the “Piramal effect,” if you will. Abbott reset expectations among India’s domestic pharma world with its $3.72 billion...

More from Deals

More from Business